BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32571958)

  • 1. CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway.
    Zhao Y; Wu H; Xing X; Ma Y; Ji S; Xu X; Zhao X; Wang S; Jiang W; Fang C; Zhang L; Yan F; Wang X
    J Pharmacol Exp Ther; 2020 Sep; 374(3):512-520. PubMed ID: 32571958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.
    Luo T; Fu J; Xu A; Su B; Ren Y; Li N; Zhu J; Zhao X; Dai R; Cao J; Wang B; Qin W; Jiang J; Li J; Wu M; Feng G; Chen Y; Wang H
    Autophagy; 2016 Aug; 12(8):1355-71. PubMed ID: 25905985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apigenin sensitizes hepatocellular carcinoma cells to doxorubic through regulating miR-520b/ATG7 axis.
    Gao AM; Zhang XY; Hu JN; Ke ZP
    Chem Biol Interact; 2018 Jan; 280():45-50. PubMed ID: 29191453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
    Kang D; Han Z; Oh GH; Joo Y; Choi HJ; Song JJ
    Yonsei Med J; 2017 Sep; 58(5):899-909. PubMed ID: 28792132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
    Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
    Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
    Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
    Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
    Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
    Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells.
    Zhang N; Wu Y; Lyu X; Li B; Yan X; Xiong H; Li X; Huang G; Zeng Y; Zhang Y; Lian J; Ni Z; He F
    Cancer Lett; 2017 Nov; 409():81-90. PubMed ID: 28889000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Xiong H; Ni Z; He J; Jiang S; Li X; He J; Gong W; Zheng L; Chen S; Li B; Zhang N; Lyu X; Huang G; Chen B; Zhang Y; He F
    Oncogene; 2017 Jun; 36(25):3528-3540. PubMed ID: 28166203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.
    Wang J; Ma L; Weng W; Qiao Y; Zhang Y; He J; Wang H; Xiao W; Li L; Chu Q; Pan Q; Yu Y; Sun F
    Hepatology; 2013 Sep; 58(3):1011-20. PubMed ID: 23532963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells.
    Du H; Yang W; Chen L; Shi M; Seewoo V; Wang J; Lin A; Liu Z; Qiu W
    Oncol Rep; 2012 Jan; 27(1):143-50. PubMed ID: 21935576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
    Huang X; Gan G; Wang X; Xu T; Xie W
    Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma.
    Fung SW; Cheung PF; Yip CW; Ng LW; Cheung TT; Chong CC; Lee C; Lai PB; Chan AW; Tsao GS; Wong CH; Chan SL; Lo KW; Cheung ST
    Cancer Lett; 2019 Aug; 457():98-109. PubMed ID: 31100412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents.
    Jia H; Yang Q; Wang T; Cao Y; Jiang QY; Ma HD; Sun HW; Hou MX; Yang YP; Feng F
    Biochim Biophys Acta; 2016 Jul; 1860(7):1417-30. PubMed ID: 27091611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
    Qin J; Luo M; Qian H; Chen W
    Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells.
    Peng WX; Xiong EM; Ge L; Wan YY; Zhang CL; Du FY; Xu M; Bhat RA; Jin J; Gong AH
    Exp Cell Res; 2016 Jan; 340(1):62-70. PubMed ID: 26708617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
    Sun Y; Xu H; Chen X; Li X; Luo B
    Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance.
    Zhang Y; Zeng S; Ma J; Deng G; Qu Y; Guo C; Shen H
    J Exp Clin Cancer Res; 2016 Jul; 35(1):111. PubMed ID: 27412382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.